Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BVS | SPRY | RLMD | ||
| Company | Bioventus Inc Cl A | Ars Pharmaceuticals Inc | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.01 | 8.26 | 6.88 | ||
| High | 9.10 | 8.51 | 7.09 | ||
| Low | 8.93 | 8.20 | 6.81 | ||
| Latest | 9.02 | 8.39 | 6.90 | ||
| Change | +0.05 | +0.09 | -0.09 | ||
| % Change | +0.56% | +1.08% | -1.29% | ||
| Volume | 416,800 | 1,142,300 | 682,600 | ||
| 20-Day Average Volume | 466,515 | 1,688,120 | 3,628,405 | ||
| Previous Close | 8.97 | 8.30 | 6.99 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.94 | 8.28 | 6.46 | ||
| 20-Day Raw Stochastic | 71.09% | 48.55% | 66.67% | ||
| 20-Day Relative Strength | 54.95 | 46.30 | 62.83 | ||
| Weighted Alpha | +30.05 | -45.24 | +485.70 | ||
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.89% since 03/27/26 | +3.97% since 03/27/26 | +7.31% since 03/27/26 | ||
| Low | 8.64 on 03/31/26 | 7.72 on 04/02/26 | 6.28 on 03/30/26 | ||
| High | 9.38 on 03/31/26 | 8.51 on 04/06/26 | 7.37 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +7.25% since 03/06/26 | -7.40% since 03/06/26 | +55.06% since 03/06/26 | ||
| Low | 8.11 on 03/09/26 | 7.20 on 03/24/26 | 5.68 on 03/24/26 | ||
| High | 9.39 on 03/27/26 | 9.65 on 03/10/26 | 7.51 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +17.91% since 01/06/26 | -24.75% since 01/06/26 | +69.12% since 01/06/26 | ||
| Low | 7.48 on 01/07/26 | 7.20 on 03/24/26 | 3.22 on 02/04/26 | ||
| High | 9.53 on 03/05/26 | 13.15 on 01/12/26 | 7.51 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +32.84% since 10/06/25 | -18.31% since 10/06/25 | +231.73% since 10/06/25 | ||
| Low | 6.37 on 10/10/25 | 6.66 on 11/21/25 | 1.80 on 10/17/25 | ||
| High | 9.53 on 03/05/26 | 13.15 on 01/12/26 | 7.51 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 745,900 | 824,165 | 733,181 | ||
| Shares Outstanding, K | 83,155 | 99,297 | 104,890 | ||
| Annual Sales | 568,090,000 | 84,280,000 | 0 | ||
| Annual Net Income | 22,730,000 | -171,300,000 | -57,390,000 | ||
| Last Quarter Sales | 157,900,000 | 28,090,000 | 0 | ||
| Last Quarter Net Income | 14,760,000 | -41,320,000 | -19,870,000 | ||
| 60-Month Beta | 0.70 | 0.86 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.24 on 03/05/26 | -0.42 on 03/09/26 | -0.27 on 03/19/26 | ||
| Latest Earnings Date | 05/05/26 | 05/13/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 13.46 | 0.00 | 0.00 | ||